Completeness of reporting of systematic reviews of diagnostic test accuracy based on the PRISMA-DTA reporting guideline

Ref ID 525
First Author J.-P. Salameh
Journal CLINICAL CHEMISTRY
Year Of Publishing 2019
URL https://watermark.silverchair.com/clinchem0291.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAsowggLGBgkqhkiG9w0BBwagggK3MIICswIBADCCAqwGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMgXfnhWhTvgr2YxWxAgEQgIICfah-aWyXrexVo_lEbbOlhrFUpfmrMKBtolWbdStjBSYWhKPwuqUqtfxI8OwAHWe93_2MTSCXXtqldG5uGHuxbg1ZGOG5008uN02QSu-GWRzo2pIhy7BKpC4mbpugJ_VxVJJ2KqAO1WuQv4c0v6gs_MepNIvJiSS7SDQtuFhdVMMJp_3USkl_XMlTAfIiJjHdDO6T5nYPx7X0t7XbqTrIGvzqWB7OFWTUEMoTo9GzbNd7EsUuO1DvCnOmruSxPAmyqFotQmflVOnY3v7MgzzynyQsnQ-WqOeAUq6kzKLscN3Ty7RU6iayKrxfgGXyGHcAy4qxwbTg-wBcGJvWRrAVwohU2-EhArX6yIsT1NvScdtS3qX4ZvOJVsiRZBhJ6mRVRazCQpz10kzE2oqeQ4HZJwyPRO5myzOpi-cucsZnHq1HCldYOgdMUX2KN2VJ7c6ZTlaz3PPm8x_x153htykME2T_D3m3Wjq99tdKWjGG1ANqu-z8GlAV80eO_aCjwMVJn_H2ojP6u9pQtDA1Eg8HFGcEb5JjKwZU9nmorQnKEfUUpZiaQ1RqQAgG78ExANCQlN5oF5TcTaa5Rf4X5726vdMIiceEFSdvhFlkWuDLVGorUIgoHUqO8aAjbrwGSIhLJ6YtE1MdQ4BBk5VGQ3yDx9hS0UozguJB1zX1zlEvCJJ3kRAQTMRT8ZxaCbdy4QNLX8ZWjUb5uSRMiCwZafSGmYFDHFn9IyIS73Khzja-b6mO8meWlwdr4h7U0QfR9HXcZ1K8tVrZ4EnrVWP3qfmuxBqpgl7qkZvlh1Eqh7YDSzKgJYIkxshvCsguVk8iMK8Kn23JtK0ALLqjZCpzFVc
Keywords • Diagnostic
• Low reporting quality
• Protocols
• Reproducibility
Problem(s) • No registered or published protocol
• Methods not described to enable replication
• Individual study characteristics not reported sufficiently
• Low reporting (PRISMA) quality
Article Type Empirical
Article Subtype Cross-sectional survey/Methodological systematic review
First Author Country Canada
Checklists • PRISMA-DTA
Aim To assess the completeness of reporting of 100 diagnostic test accuracy (DTA) systematic reviews published in MEDLINE between October 2017 to January 2018 using the (recently developed) PRISMA-DTA guidelines.
Level of Investigation Descriptive
Summary of Findings Infrequently reported items in the main reports of included systematic reviews related to protocol registration, characteristics of included studies, results synthesis, and definitions used in data extraction. Infrequently reported items from PRISMA-DTA for the included abstracts were funding information, strengths and limitations, characteristics of included studies, and assessment of applicability. Variability in reporting by country of the corresponding author was identified with Canadian authors demonstrating the most complete reporting, compared with China, which had the lowest number of reported items. Completeness of reporting of studies published in higher impact factor journals reported more items than studies published in lower impact factor journals
Number of systematic reviews included 100
Number of eligible systematic reviews assessed 881
Treatment impacted No
Treatment impacted description
Interpretation impacted Not Applicable
Interpretation impacted description